» Articles » PMID: 21082902

Laparoscopic Radiofrequency Ablation of Liver Tumors: Comparison of MR Guidance Versus Conventional Laparoscopic Ultrasound for Needle Positioning in a Phantom Model

Overview
Publisher Informa Healthcare
Date 2010 Nov 19
PMID 21082902
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Laparoscopic radiofrequency ablation (LapRFA) is an established procedure for liver tumors in patients who are unsuitable for resection. A novel technique of magnetic resonance (MR) guided needle positioning during LapRFA was developed and compared to conventional ultrasound (US) guidance in a phantom model. MR-guided procedures were conducted in a 1.0 tesla high field open MR using an MR compatible endoscope and camera. The ultrasound-guided procedure was performed with a clinically established laparoscopy setup and a 2D laparoscopic US probe. During both techniques an identical monopolar non-ferromagnetic RFA needle and a silicon-based phantom model were applied. Finally needle positioning was performed by two surgeons and one interventionalist. Time to needle placement and number of trials were recorded and statistically analyzed. MR-guided needle positioning under laparoscopic control was technically feasible. Average time to correct needle placement was 2' 6″ in the LapUS group and 1' 54″ in the MR group. The number of trials was 3.2 in the LapUS group and 2.6 in the MR group. Image quality was assessed by all participants. MR images showed a better tissue to tumor contrast and allowed an improved orientation due to multiplanar visualization. MR-guided laparoscopic RFA is a promising technique offering multiplanar needle positioning with high soft tissue contrast with immediate therapy control. In a phantom model it showed comparable results regarding needle positioning to the established technique of laparoscopic US guidance.

Citing Articles

Generic surgical process model for minimally invasive liver treatment methods.

Gholinejad M, Pelanis E, Aghayan D, Fretland A, Edwin B, Terkivatan T Sci Rep. 2022; 12(1):16684.

PMID: 36202857 PMC: 9537522. DOI: 10.1038/s41598-022-19891-1.


[Clinical application of laparoscopy-assisted and percutaneous radiofrequency ablation for hepatocellular carcinoma].

Chen S, Wang H, Zhang W, Chen J, Lu P Nan Fang Yi Ke Da Xue Xue Bao. 2018; 38(9):1147-1150.

PMID: 30377101 PMC: 6744195. DOI: 10.12122/j.issn.1673-4254.2018.09.21.


Advances in local ablation of malignant liver lesions.

Eisele R World J Gastroenterol. 2016; 22(15):3885-91.

PMID: 27099433 PMC: 4823240. DOI: 10.3748/wjg.v22.i15.3885.


Postoperative immunosuppression after open and laparoscopic liver resection: assessment of cellular immune function and monocytic HLA-DR expression.

Chopra S, Haacke N, Meisel C, Unterwalder N, Fikatas P, Schmidt S JSLS. 2014; 17(4):615-21.

PMID: 24398205 PMC: 3866067. DOI: 10.4293/108680813X13693422519677.


Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model.

Wu H, Wilkins L, Ziats N, Haaga J, Exner A Radiology. 2013; 270(1):107-16.

PMID: 23912621 PMC: 4228713. DOI: 10.1148/radiol.13121999.